| 000 | 01451 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250512021838.0 | ||
| 264 | 0 | _c19880329 | |
| 008 | 198803s 0 0 eng d | ||
| 022 | _a0004-3591 | ||
| 024 | 7 |
_a10.1002/art.1780310113 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKammer, G M | |
| 245 | 0 | 0 |
_aImpaired mobility of human T lymphocyte surface molecules during inactive systemic lupus erythematosus. Relationship to a defective cAMP pathway. _h[electronic resource] |
| 260 |
_bArthritis and rheumatism _cJan 1988 |
||
| 300 |
_a88-98 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_a4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone _xpharmacology |
| 650 | 0 | 4 |
_aAdenosine _xpharmacology |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntigens, Surface _ximmunology |
| 650 | 0 | 4 |
_aAzides _xpharmacology |
| 650 | 0 | 4 |
_aColforsin _xpharmacology |
| 650 | 0 | 4 |
_aCyclic AMP _xanalogs & derivatives |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunologic Capping _xdrug effects |
| 650 | 0 | 4 |
_aLupus Erythematosus, Systemic _ximmunology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aReceptors, Cyclic AMP _xmetabolism |
| 650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
| 700 | 1 | _aMitchell, E | |
| 773 | 0 |
_tArthritis and rheumatism _gvol. 31 _gno. 1 _gp. 88-98 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/art.1780310113 _zAvailable from publisher's website |
| 999 |
_c2836755 _d2836755 |
||